All Stories

  1. Epigenetic control of the angiotensin-converting enzyme in endothelial cells during inflammation
  2. miR-223–IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach
  3. Whatever Happened to the Epoxyeicosatrienoic Acid-Like Endothelium-Derived Hyperpolarizing Factor? The Identification of Novel Classes of Lipid Mediators and Their Role in Vascular Homeostasis
  4. Increased cerebrospinal fluid calpain activity and microparticle levels in Alzheimer's disease
  5. HIF-2α attenuates lymphangiogenesis by up-regulating IGFBP1 in hepatocellular carcinoma
  6. Role of secreted modular calcium-binding protein 1 (SMOC1) in transforming growth factor β signalling and angiogenesis
  7. HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma
  8. The number of cardiac myocytes in the hypertrophic and hypotrophic left ventricle of the obese and calorie-restricted mouse heart
  9. Electrophilic Fatty Acid Species Inhibit 5-Lipoxygenase and Attenuate Sepsis-Induced Pulmonary Inflammation
  10. Methylglyoxal Induces Platelet Hyperaggregation and Reduces Thrombus Stability by Activating PKC and Inhibiting PI3K/Akt Pathway
  11. Ca2+-sensing Receptor Cleavage by Calpain Partially Accounts for Altered Vascular Reactivity in Mice Fed a High-fat Diet
  12. Soluble epoxide hydrolase disruption as therapeutic target for wound healing
  13. Mena/VASP and αII-Spectrin complexes regulate cytoplasmic actin networks in cardiomyocytes and protect from conduction abnormalities and dilated cardiomyopathy
  14. Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques
  15. Correction: 11,12-EET Stimulates the Association of BK Channel α and β1Subunits in Mitochondria to Induce Pulmonary Vasoconstriction
  16. Hypoxic pulmonary vasoconstriction requires connexin 40–mediated endothelial signal conduction
  17. 11,12-EET Stimulates the Association of BK Channel α and β1 Subunits in Mitochondria to Induce Pulmonary Vasoconstriction
  18. Platelet Function and Signaling in Diabetes Mellitus
  19. Stereological characterization of left ventricular cardiomyocytes, capillaries, and innervation in the nondiabetic, obese mouse
  20. The F-BAR protein NOSTRIN participates in FGF signal transduction and vascular development
  21. All cut up! The consequences of calpain activation on platelet function
  22. The role of calpain in regulating platelet physiology and crosstalk with the vasculature
  23. The AMP-activated protein kinase modifies gene expression in endothelial cells by interfering with protein lysine acetylation
  24. Identification of septin-5 as a novel calpain substrate and its role in platelet secretion
  25. Human secreted modular Ca2+-binding protein 1 is involved in inflammatory matrix remodelling through interference in cytokine signalling
  26. Complementary Screening Techniques Yielded Fragments that Inhibit the Phosphatase Activity of Soluble Epoxide Hydrolase
  27. The cytochrome P450 pathway in angiogenesis and endothelial cell biology
  28. Cytochrome P450-dependent eicosanoid production and crosstalk
  29. Cytochrome P450-derived epoxyeicosatrienoic acids accelerate wound epithelialization and neovascularization in the hairless mouse ear wound model
  30. Nitric Oxide-Induced Activation of the AMP-Activated Protein Kinase α2 Subunit Attenuates IκB Kinase Activity and Inflammatory Responses in Endothelial Cells
  31. Lipid Signaling Mediators ‘mEET’ TRP Channels: Highlighted Presentations From the March 2010 Winter Eicosanoid Conference
  32. Cytochrome P450-Derived Epoxyeicosatrienoic Acids and Pulmonary Hypertension: Central Role of Transient Receptor Potential C6 Channels
  33. Activation of Adenosine-Monophosphate–Activated Protein Kinase Abolishes Desflurane-Induced Preconditioning Against Myocardial Infarction In Vivo
  34. Biology of Nitric Oxide Synthases
  35. Soluble Epoxide Hydrolase Limits Mechanical Hyperalgesia during Inflammation
  36. Adipocyte-derived lipids increase angiotensin-converting enzyme (ACE) expression and modulate macrophage phenotype
  37. Epoxyeicosatrienoic acids and endothelium-dependent responses
  38. The Role of Calpain in Diabetes-Associated Platelet Hyperactivation
  39. Molecular mechanisms underlying the activation of eNOS
  40. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats
  41. The S1P2 receptor expressed in human platelets is linked to the RhoA-Rho kinase pathway and is down regulated in type 2 diabetes
  42. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats
  43. Impaired interaction of platelets with endothelial progenitor cells in patients with cardiovascular risk factors
  44. Biology of Nitric Oxide Synthases
  45. Vascular Cytochrome P450 Enzymes: Physiology and Pathophysiology
  46. O75. Angiotensin II inactivates eNOS through tyrosine phosphorylation
  47. Dr. Rudi Busse
  48. Rudi Busse
  49. Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure
  50. The effects of COX-2 selective and non-selective NSAIDs on the initiation and progression of atherosclerosis in ApoE−/− mice
  51. Epoxyeicosatrienoic acids, cell signaling and angiogenesis
  52. From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: Epoxyeicosatrienoic acids (EETs) and cell signaling
  53. The shear stress-induced activation of the AMP-activated protein kinase (AMPK) regulates FoxO1a activity and angiopoietin-2 expression in endothelial cells
  54. Angiotensin converting enzyme (ACE) inhibitors induce an ACE-dependent signalling in endothelial cells via the initial dimerisation of ACE
  55. P186. Tyrosine phosphorylation of the nitric oxide synthase by PYK2 attenuates enzyme activity
  56. Epoxyeicosatrienoic acids: regulators of vascular homeostasis
  57. The tissue renin–angiotensin system and intracellular signalling
  58. Nitric oxide– and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9
  59. Analysis of Dichlorodihydrofluorescein and Dihydrocalcein as Probes for the Detection of Intracellular Reactive Oxygen Species
  60. The Physiology of Nitric Oxide: Control and Consequences
  61. Bradykinin-induced relaxation of coronary microarteries: S -nitrosothiols as EDHF?
  62. OUTSIDE-IN SIGNALLING BY THE ANGIOTENSIN CONVERTING ENZYME IN ENDOTHELIAL CELLS: A NOVEL SIGNALLING PATHWAY
  63. INSULIN INDUCES THE RELEASE OF VASODILATOR COMPOUNDS FROM PLATELETS BY A NITRIC OXIDE/G KINASE/VAMP-3-DEPENDENT PATHWAY: A NOVEL MECHANISM OF INSULIN-INDUCED VASODILATATION
  64. 865-1 Endothelium-derived hyperpolarizing factor is involved in flow-dependent dilation of peripheral conduit arteries in healthy volunteers
  65. Dialogue entre cellules endothéliales et cellules musculaires lisses
  66. Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole
  67. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets
  68. Identification of a cis -Element Regulating Transcriptional Activity in Response to Fluid Shear Stress in Bovine Aortic Endothelial Cells
  69. Insulin enhances the expression of the endothelial nitric oxide synthase in native endothelial cells: a dual role for Akt and AP-1
  70. Characterization of the endothelium-derived hyperpolarizing factor (EDHF) response in the human interlobar artery
  71. Cytochrome P450 epoxygenases and vascular tone: novel role for HMG-CoA reductase inhibitors in the regulation of CYP 2C expression
  72. Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces
  73. Cytochrome P450 2C9 plays an important role in the regulation of exercise‐induced skeletal muscle blood flow and oxygen uptake in humans
  74. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase: Fig. 1.
  75. The Na-K-ATPase is a target for an EDHF displaying characteristics similar to potassium ions in the porcine renal interlobar artery
  76. EDHF: bringing the concepts together
  77. Cirrhosis serum induces a nitric oxide-associated vascular hyporeactivity of aortic segments from healthy rats in vitro
  78. The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells
  79. EDHF: A cytochrome P450 metabolite in coronary arteries
  80. Endothelium-Derived Hyperpolarizing Factor and Its Interaction with NO
  81. Activation of NOS by Ca2+-Dependent and Ca2+-Independent Mechanisms
  82. Nitric oxide, nitric oxide synthase, and hypertensive vascular disease
  83. Regulation of NO Synthesis in Endothelial Cells
  84. Pulsatile Stretch and Shear Stress: Physical Stimuli Determining the Production of Endothelium-Derived Relaxing Factors
  85. Tyrosine Phosphorylation and Bradykinin-Induced Signaling in Endothelial Cells
  86. Vascular Effects of NO
  87. Calcium-Dependent and Calcium-Independent Activation of the Endothelial NO Synthase
  88. Paracrine functions of the coronary vascular endothelium
  89. Endothelial Dysfunction in Atherosclerosis
  90. Paracrine functions of the coronary vascular endothelium
  91. Calcium Signalling and Autacoid Production in Endothelial Cells Are Modulated by Changes in Tyrosine Kinase and Phosphatase Activity
  92. Regulation and Functional Consequences of Endothelial Nitric Oxide Formation
  93. Control and Consequences of Endothelial Nitric Oxide Formation
  94. Regulation of Platelet Function by Flow-Induced Release of Endothelial Autacoids
  95. Mechanisms of Shear Stress-Dependent Endothelial Nitric Oxide Release: Cardiovascular Implications
  96. The endothelial organ
  97. Endothelium-Derived Bradykinin
  98. Endothelium-Derived Kinins Account for the Immediate Response of Endothelial Cells to Bacterial Lipopoly saccharide
  99. Effect of endotoxin on circulating cyclic GMP in the rat
  100. Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells
  101. The effect of inhibitors of the l-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats
  102. Evidence that an l-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin
  103. Activation of the l-Arginine-Nitric Oxide Pathway Is Involved in Vascular Hyporeactivity Induced by Endotoxin
  104. Activation of the L-Arginine-Nitric Oxide Pathway Is Involved in Vascular Hyporeactivity Induced by Endotoxin
  105. An L-arginine-derived factor mediates endotoxin-induced vascular hyposensitivity to calcium
  106. Incubation with endotoxin activates the L-arginine pathway in vascular tissue
  107. Incubation with endotoxin (ETX) induces vascular hyporeactivity which is reversed by NGmonomethyl-L-arginine (L-NMMA)
  108. Endothelial function is impaired in aortae from lipopolysaccharide (LPS)-treated rats